Inovin Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Manimajra, Chandigarh, India, established in 2018.

2018 Manimajra, Chandigarh, India Active

Last Updated: January 06, 2026

About Inovin Pharmaceuticals Private Limited

Inovin Pharmaceuticals Private Limited, a active private limited company, was established on 25 May 2018 in Manimajra, Chandigarh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999CH2018PTC042017. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rishabh Garg (Additional Director), Manav Garg (Director). Past directors included Deepak Kumar Garg, Sonal Singla. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Scf No. 265, Second Floor Motor Market, Manimajra, Chandigarh, 160101.

Company Details

CIN/LLPIN
U74999CH2018PTC042017
Registration Number
042017
Incorporation Date
25 May 2018
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Chandigarh
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.10 M as on 06-01-2026
Paid Up Capital ₹ 0.10 M as on 06-01-2026
Company Age 7 Year, 8 Months
Last Filing with ROC 31 Mar 2025

Comprehensive Company Insights

Explore comprehensive insights into Inovin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Inovin Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rishabh Garg	Additional Director	13 Jan 2020	Current
Manav Garg	Director	02 Jan 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	02 Jan 2023	Past
Pramod Abcsdd	Director	13 Jan 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Inovin Pharmaceuticals.

Enhance accessibility to Inovin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Inovin Pharmaceuticals?

Unlock access to Inovin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Inovin Pharmaceuticals?

Unlock and access historical data on people associated with Inovin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Inovin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inovin Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Inovin Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Inovin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Balance Sheet

Inovin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.
31 Mar 2025
Director Appointment

Progress on Manav Garg was appointed as a Director was appointed as a Director on 02 Jan 2023 & has been associated with this company since 3 years 1 month . was documented.
02 Jan 2023
Director Appointment

The activity Rishabh Garg was appointed as a Additional Director was appointed as a Additional Director on 13 Jan 2020 & has been associated with this company since 6 years 1 month . was completed.
13 Jan 2020
Company Incorporation

Inovin Pharmaceuticals Private Limited was registered on 25 May 2018 with Roc Chandigarh & aged 7 years 8 months as per MCA records. was recorded as a recent event.
25 May 2018

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Inovin Pharmaceuticals Private Limited?

The CIN of Inovin Pharmaceuticals Private Limited is U74999CH2018PTC042017.

Where is Inovin Pharmaceuticals Private Limited headquartered?

Inovin Pharmaceuticals Private Limited is headquartered at Scf No. 265, Second Floor Motor Market, Manimajra, Chandigarh, 160101.

When was Inovin Pharmaceuticals Private Limited incorporated?

Inovin Pharmaceuticals Private Limited was incorporated on 25 May 2018.

Who are the current directors of Inovin Pharmaceuticals Private Limited?

The current directors of Inovin Pharmaceuticals Private Limited are

What is the primary industry of Inovin Pharmaceuticals Private Limited?

The primary industry of Inovin Pharmaceuticals Private Limited is Pharma.

Is Inovin Pharmaceuticals Private Limited a listed company?

Inovin Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Inovin Pharmaceuticals Private Limited?

The authorized capital of Inovin Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available